Using antimicrobial matrices to help heal complex diabetic foot ulcers.
Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs.
['FUNDING_SBIR_2'] · GEL4MED, INC. · NIH-10918299
This study is testing a new treatment called G4Derm for people with severe diabetic foot ulcers, aiming to help these tough wounds heal better and faster while keeping them safe from infections.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEL4MED, INC. (nih funded) |
| Locations | 1 site (BRIGHTON, UNITED STATES) |
| Trial ID | NIH-10918299 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new treatment for diabetic foot ulcers (DFUs) that have progressed to a more severe stage, known as DTU-DFUs. The approach involves using a biosynthetic product called G4Derm, which is designed to fill complex wounds and promote healing while preventing infections. The product is easy to apply and works by creating a supportive matrix that encourages tissue regeneration. By addressing the challenges of current treatments, this research aims to improve healing outcomes for patients with difficult-to-treat wounds.
Who could benefit from this research
Good fit: Ideal candidates for this research are diabetic patients suffering from advanced foot ulcers that are at risk of infection and complications.
Not a fit: Patients with non-diabetic foot ulcers or those whose wounds are not complex may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of infection and improve healing rates for patients with complex diabetic foot ulcers.
How similar studies have performed: Previous research has shown promising results with similar antimicrobial approaches in wound care, suggesting potential for success in this novel application.
Where this research is happening
BRIGHTON, UNITED STATES
- GEL4MED, INC. — BRIGHTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MEHTA, MANAV — GEL4MED, INC.
- Study coordinator: MEHTA, MANAV
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bone Infection